BackReplimune Group Overview

Replimune Group Long Term Debt

Track Replimune Group's long-term debt ($24M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$24.24M

Peer average

Loading

Replimune Group Long Term Debt History

Loading

Replimune Group vs. peers: Long Term Debt Comparison

Loading

Replimune Group Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Replimune Group (REPL) FAQ

As of the most recent data (March 2026), REPL shows a long-term debt of $24M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REPL's long-term debt is now $24M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Replimune Group is outperforming or lagging.

Tracking REPL's long-term debt over time shows whether Replimune Group is scaling, shrinking, or reshaping that part of the business. The current reading is $24M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Replimune Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $24M) with ownership activity and broader fundamentals.

Replimune Group's long-term debt is $24M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.